Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results
|
BioXcel Therapeutics, Inc. (BTAI)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
04/14/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
07/05/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
01/19/2022 |
3
| Wiley Matthew T. (CHIEF COMMERCIAL OFFICER) has filed a Form 3 on BioXcel Therapeutics, Inc. |
03/03/2021 |
3
| Bray June (Director) has filed a Form 3 on BioXcel Therapeutics, Inc. |
02/24/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/23/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/17/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
05/04/2020 |
3
| BioXcel Holdings, Inc. (10% Owner) has filed a Form 3 on BioXcel Therapeutics, Inc. |
03/18/2019 |
3
| Votruba Michal (Director) has filed a Form 3 on BioXcel Therapeutics, Inc. |
03/07/2018 |
3
| Steinhart Richard I (CFO) has filed a Form 3 on BioXcel Therapeutics, Inc. |
03/07/2018 |
3
| Yocca Frank (Chief Scientific Officer) has filed a Form 3 on BioXcel Therapeutics, Inc. |
03/07/2018 |
3
| O'Neill Vincent (Chief Medical Officer) has filed a Form 3 on BioXcel Therapeutics, Inc. |
03/07/2018 |
3
| Mehta Vimal (CEO, President, Secretary) has filed a Form 3 on BioXcel Therapeutics, Inc. |
03/07/2018 |
3
| BioXcel Corp (10% Owner) has filed a Form 3 on BioXcel Therapeutics, Inc. |
03/07/2018 |
3
| MUELLER PETER (Director) has filed a Form 3 on BioXcel Therapeutics, Inc. |
03/07/2018 |
3
| Nandabalan Krishnan (10% Owner) has filed a Form 3 on BioXcel Therapeutics, Inc. |
03/07/2018 |
3
| Laumas Sandeep (Director) has filed a Form 3 on BioXcel Therapeutics, Inc. |
|
|